Disability News and Research

RSS

New genome editing tool used to heal genetic disease

Parents of newborns may be familiar with the metabolic disorder phenylketonuria: in Switzerland, all newborn babies are screened for this genetic disease.

8 Oct 2018

FDA and EMA accept Novartis' regulatory application for siponimod to treat SPMS in adults

Novartis today announced that both the US Food and Drug Administration and European Medicines Agency have accepted the company's New Drug Application and Marketing Authorization Application respectively, for investigational oral, once-daily siponimod (BAF312) for the treatment of secondary progressive multiple sclerosis in adults.

8 Oct 2018

Nonfatal injuries in the U.S. cost over $1.8 trillion in 2013

A new analysis by researchers from Brown University and the Pacific Institute for Research and Evaluation has found that nonfatal injuries in the U.S. in the year 2013 cost more than $1.8 trillion.

8 Oct 2018

Study: Chemotherapy drugs may promote muscle mitochondrial dysfunction

Chemotherapy drugs to treat breast cancer may promote muscle mitochondrial dysfunction, according to new research. Dysfunctional mitochondria, the energy centers of the cells, may contribute to fatigue and weakness that some people with breast cancer experience through the course of disease treatment.

5 Oct 2018

Without safety net of kids or spouse, ‘elder orphans’ need fearless fallback plan

It was a memorable place to have an "aha" moment about aging. Peter Sperry had taken his 82-year-old father, who'd had a stroke and used a wheelchair, to Disney World. Just after they'd made their way through the Pirates of the Caribbean ride, nature called. Sperry took his father to the bathroom where, with difficulty, he changed the older man's diaper.

4 Oct 2018

New molecular interaction governs formation of specific connections between neurons

Researchers at VIB and KU Leuven have uncovered a new molecular interaction that governs the formation of specific functional connections between two types of neurons.

3 Oct 2018

New supplemental health products launched to complement Anthem medical plans

Anthem Blue Cross and Blue Shield now offers employer-sponsored voluntary accident, critical illness and hospital indemnity insurance products, for effective dates beginning January 1, 2019.

3 Oct 2018

Infants face high thrombosis risk

Russian scientists have carried out tests to compare the process of blood coagulation in adults and newborns and discovered that the latter face an increased risk of thrombosis.

1 Oct 2018

Researchers examine factors associated with mortality post- traumatic brain injury

Model system researchers have examined the factors associated with mortality among individuals aged 16 years and older who were more than one year post- traumatic brain injury.

29 Sep 2018

Insilico Medicine collaborates with MAWI to develop multi-modal biomarkers of aging

Cardiovascular disease is the leading cause of death and disability in the world. On the eve of the annual World Heart Day, September 29th, Insilico Medicine, Inc., a Rockville-based next-generation artificial intelligence company specializing in the application of deep learning for target identification, drug discovery and aging research announced a research collaboration agreement with MAWI, the next-generation consumer and clinical wearable company, the developer of one of the most accurate clinical-grade ECG wearable devices.

28 Sep 2018

Taken for a ride: After ATV crash, doctor gets $56,603 bill for air ambulance trip

It was the first — and only — time Dr. Naveed Khan, a 35-year-old radiologist, ever rode in an all-terrain vehicle.

28 Sep 2018

Study reveals how a person's social network affects neurological outcomes

Are healthy and unhealthy habits contagious? Can a person's social network influence their risk of disease? It's a contentious idea but one that researchers want to explore in the future and better understand.

27 Sep 2018

Machine learning may be useful tool to predict outcomes for people at risk of psychosis, depression

Machine learning, also known as artificial intelligence, could be a useful tool for predicting how well people at high risk of psychosis or with recent onset depression will function socially in the future, an international research study has found.

26 Sep 2018

5 things to know about Trump’s new ‘public charge’ immigration proposal

A proposed rule from the White House would make it harder for legal immigrants to get green cards if they have received certain kinds of public assistance — including Medicaid, food stamps and housing subsidies. Green cards allow them to live and work permanently in the United States.

25 Sep 2018

DFG establishes nine new Research Units

The Deutsche Forschungsgemeinschaft is establishing nine new Research Units, following a decision by the Senate and the Joint Committee in Bonn.

25 Sep 2018

‘Trouble Brewing’ report highlights steps that governments can take to reduce alcohol-related harms

Alcohol is a leading contributor to death and disability worldwide, but governments haven’t responded to the issue with the attention, resources and action this urgent issue requires, says “Trouble Brewing,” a new report from global health and development organizations, Vital Strategies, the NCD Alliance, IOGT International and the Global Alcohol Policy Alliance.

25 Sep 2018

Researchers find impact of neurobehavioral symptoms on employment in adults with TBI

Kessler Foundation researchers have published their findings linking behavioral symptoms with employment outcomes among adults with moderate to severe traumatic brain injury.

24 Sep 2018

Lumos acquires license for LUM-201 drug that promotes secretion of growth hormone

Lumos Pharma, Inc., a clinical stage biopharmaceutical company focused on development and commercialization of therapeutics for rare and neglected diseases, today announced that it has acquired the license for LUM-201, an investigational orally administered small molecule that promotes secretion of growth hormone from the pituitary gland, from Ammonett Pharma LLC.

24 Sep 2018

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

Alexion Pharmaceuticals, Inc. today announced positive topline results from the Phase 3 PREVENT study of Soliris in patients with anti-aquaporin-4 auto antibody-positive neuromyelitis optica spectrum disorder.

24 Sep 2018

MS Society: Link between smoking and multiple sclerosis is 'clearer than ever'

The link between smoking and multiple sclerosis (MS) is “clearer than ever”, the MS Society has announced. Not only are people who smoke more likely to develop MS, smoking can also speed up how fast people with MS become disabled.

24 Sep 2018

Disability News and Research

New genome editing tool used to heal genetic disease

FDA and EMA accept Novartis' regulatory application for siponimod to treat SPMS in adults

Nonfatal injuries in the U.S. cost over $1.8 trillion in 2013

Study: Chemotherapy drugs may promote muscle mitochondrial dysfunction

Without safety net of kids or spouse, ‘elder orphans’ need fearless fallback plan

New molecular interaction governs formation of specific connections between neurons

New supplemental health products launched to complement Anthem medical plans

Infants face high thrombosis risk

Researchers examine factors associated with mortality post- traumatic brain injury

Insilico Medicine collaborates with MAWI to develop multi-modal biomarkers of aging

Taken for a ride: After ATV crash, doctor gets $56,603 bill for air ambulance trip

Study reveals how a person's social network affects neurological outcomes

Machine learning may be useful tool to predict outcomes for people at risk of psychosis, depression

5 things to know about Trump’s new ‘public charge’ immigration proposal

DFG establishes nine new Research Units

‘Trouble Brewing’ report highlights steps that governments can take to reduce alcohol-related harms

Researchers find impact of neurobehavioral symptoms on employment in adults with TBI

Lumos acquires license for LUM-201 drug that promotes secretion of growth hormone

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

MS Society: Link between smoking and multiple sclerosis is 'clearer than ever'

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News